COCA-COLA EUROPACIFIC PARTNE (CCEP) Forecast, Price Target & Analyst Ratings

Name: COCA-COLA EUROPACIFIC PARTNE (CCEP) Analyst Consensus Rating
Brand: COCA-COLA EUROPACIFIC PARTNE
Rating: 7.5 (22 reviews)

NASDAQ:CCEP • GB00BDCPN049

92.79 USD

-0.44 (-0.47%)

At close: Mar 26, 2026

92.83 USD

+0.04 (+0.04%)

Pre-Market: 3/27/2026, 6:27:05 AM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COCA-COLA EUROPACIFIC PARTNE (CCEP).

Consensus Price Target

Price Target

$110.03

+ 18.58% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Apr 28, 2026

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

75.45%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$110.03

Upside

+ 18.58%

From current price of $92.79 to mean target of $110.03, Based on 22 analyst forecasts

Low

$91.81

Median

$112.71

High

$126.40

Price Target Revisions

1 Month

8.26%

3 Months

7.69%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for CCEP. The average price target is 110.03 USD. This implies a price increase of 18.58% is expected in the next year compared to the current price of 92.79.

The average price target has been revised upward by 7.69% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

75.45%

CCEP was analyzed by 22 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CCEP.

In the previous month the buy percentage consensus was at a similar level.

CCEP was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2026-02-19	Barclays	Maintains	Overweight -> Overweight
2026-02-18	UBS	Maintains	Buy -> Buy
2026-02-18	Evercore ISI Group	Maintains	Outperform -> Outperform
2026-02-18	JP Morgan	Maintains	Neutral -> Neutral
2026-02-18	Goldman Sachs	Maintains	Buy -> Buy
2026-01-14	B of A Securities	Downgrade	Buy -> Neutral
2026-01-08	UBS	Maintains	Buy -> Buy
2025-08-08	Barclays	Maintains	Overweight -> Overweight
2025-07-15	Barclays	Maintains	Overweight -> Overweight
2025-07-02	UBS	Maintains	Buy -> Buy
2025-05-01	Barclays	Maintains	Overweight -> Overweight
2025-04-30	UBS	Maintains	Buy -> Buy
2025-04-11	Barclays	Maintains	Overweight -> Overweight
2025-03-27	Barclays	Maintains	Overweight -> Overweight
2025-03-06	Barclays	Maintains	Overweight -> Overweight
2025-02-18	Evercore ISI Group	Maintains	Outperform -> Outperform
2025-01-17	Barclays	Maintains	Overweight -> Overweight
2024-12-12	UBS	Maintains	Buy -> Buy
2024-12-03	Bernstein	Initiate	Market Perform
2024-11-27	JP Morgan	Downgrade	Overweight -> Neutral
2024-11-07	Barclays	Maintains	Overweight -> Overweight
2024-11-06	Evercore ISI Group	Maintains	Outperform -> Outperform
2024-10-11	Barclays	Maintains	Overweight -> Overweight
2024-09-09	Deutsche Bank	Maintains	Buy -> Buy
2024-08-09	Barclays	Maintains	Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date: Apr 28, 2026

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

N/A

EPS (3 Months)

N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	18.302B 5.67%	20.438B 11.67%	20.901B 2.27%	21.925B 4.90%	22.767B 3.84%	23.67B 3.97%	24.889B 5.15%	26.088B 4.82%
EBITDA YoY % growth	3.127B 4.37%	3.397B 8.63%	3.612B 6.33%	3.98B 10.19%	4.227B 6.21%	4.505B 6.58%	4.901B 8.79%	5.104B 4.14%
EBIT YoY % growth	2.335B 7.11%	2.464B 5.52%	2.689B 9.13%	3.03B 12.68%	3.241B 6.96%	3.451B 6.48%	3.673B 6.43%	3.927B 6.92%
Operating Margin	12.76%	12.06%	12.87%	13.82%	14.24%	14.58%	14.76%	15.05%
EPS YoY % growth	N/A 8.74%	N/A 6.84%	N/A 4.29%	4.54 8.59%	4.96 9.38%	5.40 8.81%	5.86 8.40%	6.72 14.84%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates


EPS Q2Q % growth
Revenue Q2Q % growth
EBITDA Q2Q % growth
EBIT Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

8.93%

EPS Next 5 Year

9.98%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

3.48%

Revenue Next 5 Year

4.08%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

17.83%

EBIT Next 5 Year

13.13%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COCA-COLA EUROPACIFIC PARTNE / CCEP Forecast FAQ

What do analysts expect the price target to be for COCA-COLA EUROPACIFIC PARTNE (CCEP)?

22 analysts have analysed CCEP and the average price target is 110.03 USD. This implies a price increase of 18.58% is expected in the next year compared to the current price of 92.79.

When does COCA-COLA EUROPACIFIC PARTNE (CCEP) report earnings?

COCA-COLA EUROPACIFIC PARTNE (CCEP) will report earnings on 2026-04-28.

What is the number of analysts for CCEP stock?

The number of analysts covering COCA-COLA EUROPACIFIC PARTNE (CCEP) is 22.

Analyst forecast overview

Forecast Snapshot